Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies

The Journal of Clinical PharmacologyVolume 52, Issue 10 p. 1601-1606 Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies Yaning Wang PhD, Corresponding Author Yaning Wang PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration. Address for correspondence: Yaning Wang, Division of Pharmacometrics, Office of Clinical Pharmacology, 10903 New Hampshire Avenue, Bldg #51, Rm 1252, Silver Spring, MD 20903; e-mail: Yaning.Wang@fda.hhs.gov.Search for more papers by this authorPravin R. Jadhav PhD, Pravin R. Jadhav PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this authorMallika Lala PhD, Mallika Lala PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this authorJogarao V. Gobburu PhD, Jogarao V. Gobburu PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this author Yaning Wang PhD, Corresponding Author Yaning Wang PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration. Address for correspondence: Yaning Wang, Division of Pharmacometrics, Office of Clinical Pharmacology, 10903 New Hampshire Avenue, Bldg #51, Rm 1252, Silver Spring, MD 20903; e-mail: Yaning.Wang@fda.hhs.gov.Search for more papers by this authorPravin R. Jadhav PhD, Pravin R. Jadhav PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this authorMallika Lala PhD, Mallika Lala PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this authorJogarao V. Gobburu PhD, Jogarao V. Gobburu PhD Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.Search for more papers by this author First published: 07 March 2013 https://doi.org/10.1177/0091270011422812Citations: 66Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume52, Issue10October 2012Pages 1601-1606 RelatedInformation